Your browser doesn't support javascript.
loading
A novel differentiation-inducing therapy for acute promyelocytic leukemia with a combination of arsenic trioxide and GM-CSF.
Muto, A; Kizaki, M; Kawamura, C; Matsushita, H; Fukuchi, Y; Umezawa, A; Yamada, T; Hata, J; Hozumi, N; Yamato, K; Ito, M; Ueyama, Y; Ikeda, Y.
Affiliation
  • Muto A; Department of Internal Medicine, Keio University School of Medicine, Tokyo, Japan.
Leukemia ; 15(8): 1176-84, 2001 Aug.
Article in En | MEDLINE | ID: mdl-11480559
Subject(s)
Search on Google
Add to My VHL
Print
XML
PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Oxides / Arsenicals / Leukemia, Promyelocytic, Acute / Granulocyte-Macrophage Colony-Stimulating Factor / Antineoplastic Agents Type of study: Prognostic_studies Limits: Animals / Humans Language: En Journal: Leukemia Journal subject: HEMATOLOGIA / NEOPLASIAS Year: 2001 Document type: Article Affiliation country: Country of publication:
Search on Google
Add to My VHL
Print
XML
PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Oxides / Arsenicals / Leukemia, Promyelocytic, Acute / Granulocyte-Macrophage Colony-Stimulating Factor / Antineoplastic Agents Type of study: Prognostic_studies Limits: Animals / Humans Language: En Journal: Leukemia Journal subject: HEMATOLOGIA / NEOPLASIAS Year: 2001 Document type: Article Affiliation country: Country of publication: